chr17-80108705-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The highest continental population minor allele frequency for c.1203G>A (p.Gln401=) in gnomAD v2.1.1 is 0.74003 in the European non-Finnish population. Note that the minor allele frequency is even higher in the Ashkenazi Jewish (0.77901) and European Finnish (0.76403) populations. These allele frequencies are higher than the ClinGen LSD VCEP’s BA1 threshold (>0.01), meeting this criterion. There is a ClinVar entry for this variant (Variation ID: 92461, two star review status), with 7 submitters classifying the variant as benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA145749/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.65 ( 33470 hom., cov: 32)
Exomes 𝑓: 0.71 ( 372540 hom. )

Consequence

GAA
NM_000152.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:16

Conservation

PhyloP100: 3.60

Publications

39 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.1203G>Ap.Gln401Gln
synonymous
Exon 8 of 20NP_000143.2P10253
GAA
NM_001079803.3
c.1203G>Ap.Gln401Gln
synonymous
Exon 9 of 21NP_001073271.1P10253
GAA
NM_001079804.3
c.1203G>Ap.Gln401Gln
synonymous
Exon 8 of 20NP_001073272.1P10253

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.1203G>Ap.Gln401Gln
synonymous
Exon 8 of 20ENSP00000305692.3P10253
GAA
ENST00000390015.7
TSL:1
c.1203G>Ap.Gln401Gln
synonymous
Exon 9 of 21ENSP00000374665.3P10253
GAA
ENST00000933406.1
c.1203G>Ap.Gln401Gln
synonymous
Exon 8 of 20ENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.655
AC:
99563
AN:
151984
Hom.:
33457
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.558
Gnomad ASJ
AF:
0.771
Gnomad EAS
AF:
0.538
Gnomad SAS
AF:
0.662
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.667
GnomAD2 exomes
AF:
0.669
AC:
165746
AN:
247614
AF XY:
0.684
show subpopulations
Gnomad AFR exome
AF:
0.530
Gnomad AMR exome
AF:
0.474
Gnomad ASJ exome
AF:
0.780
Gnomad EAS exome
AF:
0.528
Gnomad FIN exome
AF:
0.764
Gnomad NFE exome
AF:
0.740
Gnomad OTH exome
AF:
0.722
GnomAD4 exome
AF:
0.712
AC:
1039092
AN:
1460166
Hom.:
372540
Cov.:
81
AF XY:
0.713
AC XY:
517684
AN XY:
726364
show subpopulations
African (AFR)
AF:
0.532
AC:
17823
AN:
33478
American (AMR)
AF:
0.489
AC:
21804
AN:
44626
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
20439
AN:
26132
East Asian (EAS)
AF:
0.560
AC:
22202
AN:
39676
South Asian (SAS)
AF:
0.673
AC:
58064
AN:
86216
European-Finnish (FIN)
AF:
0.766
AC:
39901
AN:
52114
Middle Eastern (MID)
AF:
0.795
AC:
4585
AN:
5764
European-Non Finnish (NFE)
AF:
0.730
AC:
811470
AN:
1111822
Other (OTH)
AF:
0.709
AC:
42804
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
20193
40386
60579
80772
100965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19914
39828
59742
79656
99570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.655
AC:
99607
AN:
152102
Hom.:
33470
Cov.:
32
AF XY:
0.653
AC XY:
48547
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.530
AC:
21990
AN:
41496
American (AMR)
AF:
0.556
AC:
8509
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.771
AC:
2674
AN:
3470
East Asian (EAS)
AF:
0.538
AC:
2767
AN:
5146
South Asian (SAS)
AF:
0.661
AC:
3193
AN:
4832
European-Finnish (FIN)
AF:
0.775
AC:
8214
AN:
10598
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.736
AC:
50014
AN:
67958
Other (OTH)
AF:
0.667
AC:
1405
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1685
3370
5054
6739
8424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.700
Hom.:
29218
Bravo
AF:
0.635
Asia WGS
AF:
0.587
AC:
2044
AN:
3478
EpiCase
AF:
0.741
EpiControl
AF:
0.741

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
Glycogen storage disease, type II (7)
-
-
5
not specified (5)
-
1
3
not provided (4)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
4.9
DANN
Benign
0.47
PhyloP100
3.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800304; hg19: chr17-78082504; COSMIC: COSV56407152; COSMIC: COSV56407152; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.